<p>先锋集团在最近向证券交易委员会的披露中表示，在第四季度将其在蓝鸟公司（NASDAQ:BLBD - 免费报告）股票的持股比例提高了 7.1%。该基金在季度内购买了 135,562 股后，持有该公司 2,041,085 股股票。截至其最近的 SEC 备案，先锋集团持有蓝鸟约 6.46% 的股份，价值为 95,931,000 美元。</p>
<ul>
<li>对于看涨投资者的三大高风险高回报投资</li>
</ul>
<p>其他对冲基金也对该公司的持仓进行了调整。凯通国际资产管理有限公司在第三季度将其在蓝鸟的持股比例提高了 10,028.6%。凯通国际资产管理有限公司现在拥有 709 股该公司的股票，价值 41,000 美元，此前在上个季度又购买了 702 股。拉森金融集团在第三季度将其在蓝鸟的持仓提高了 1,742.3%。拉森金融集团现在拥有 1,308 股该公司的股票，价值 75,000 美元，此前在此期间又购买了 1,237 股。NewEdge Advisors LLC 在第一季度将其在蓝鸟的持仓提高了 30.9%。NewEdge Advisors LLC 现在拥有 2,885 股该公司的股票，价值 93,000 美元，此前在此期间又购买了 681 股。LSV 资产管理公司在第三季度购买了蓝鸟的新头寸，价值 98,000 美元。最后，琼斯金融公司在第三季度将其在蓝鸟的持仓提高了 184.0%。琼斯金融公司现在拥有 1,903 股该公司的股票，价值 110,000 美元，此前在此期间又购买了 1,233 股。机构投资者和对冲基金持有该公司 93.59% 的股票。</p>
<h2>蓝鸟股价上涨 2.4%</h2>
<p>NASDAQ:BLBD 周四开盘价为 71.00 美元。该公司的 50 日移动平均线为 59.99 美元，200 日移动平均线为 54.94 美元。公司的债务与股本比率为 0.28，流动比率为 1.83，速动比率为 1.27。蓝鸟公司的 12 个月低点为 37.68 美元，12 个月高点为 81.51 美元。该公司的市值为 22.5 亿美元，市盈率为 17.44，市盈率增长比率为 0.97，贝塔值为 1.38。</p>
<ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
<p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最近于 5 月 6 日发布了季度财报。该公司报告季度每股收益为 1.00 美元，超出市场共识预期的 0.88 美元，超出 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司季度收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。去年同期，该公司每股收益为 0.96 美元。与去年同期相比，该公司的收入下降了 1.7%。研究分析师预测蓝鸟公司在当前财政年度将发布 4.35 美元的每股收益。</p>
<h2>内部活动</h2>
<p>在其他蓝鸟新闻中，首席财务官 Razvan Radulescu 于 2 月 19 日星期四出售了 3,925 股该公司的股票。股票以平均价格 60.98 美元出售，总价值为 239,346.50 美元。交易后，首席财务官直接持有 42,255 股该公司的股票，价值为 2,576,709.90 美元。这笔交易代表其持股比例减少了 8.50%。该交易在向 SEC 提交的文件中披露，文件可通过此超链接获取。此外，首席运营官 Jeffrey Scott Sanfrey 于 3 月 4 日星期三出售了 5,192 股该公司的股票。股票以平均价格 58.54 美元出售，总价值为 303,939.68 美元。交易完成后，首席运营官直接持有 39,011 股该公司的股票，价值为 2,283,703.94 美元。这笔交易代表其持股比例减少了 11.75%。该销售的 SEC 备案提供了更多信息。公司内部人士持有该公司 1.10% 的股票。</p>
<h2>分析师评级变动</h2>
<ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
<p>几家券商最近对 BLBD 进行了评估。华尔街 Zen 在 2 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “买入”。Freedom Capital 在 5 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “持有”。Zacks Research 在周一的研究报告中将蓝鸟的评级从 “持有” 下调至 “强烈卖出”。Needham &amp; Company LLC 在 5 月 7 日的研究报告中将蓝鸟的目标价从 78.00 美元提高至 86.00 美元，并给予该股票 “买入” 评级。最后，巴克莱在 5 月 7 日的研究报告中将蓝鸟的目标价从 55.00 美元提高至 75.00 美元，并给予该股票 “增持” 评级。六位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，蓝鸟目前的平均评级为 “适度买入”，共识目标价为 75.80 美元。</p>
<p><strong>获取我们最新的蓝鸟股票分析</strong></p>
<h2>关于蓝鸟</h2>
<p>（免费报告）</p>
<p>蓝鸟公司（NASDAQ: BLBD）是总部位于乔治亚州福特谷的领先公交车和公共交通工具制造商。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）模型、公交风格（D 型）模型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩展了其产品，推出了零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
<p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票而非 Blue Bird</li>
<li>D-Wave 的财报表现疲软，但投资者可能忽视了这一点</li>
<li>随着 AI 反馈循环加剧，Nebius 的上行空间扩大</li>
<li>内部交易：Okta 和 Abbott 看到买入，Micron 内部人士卖出</li>
<li>Plug Power 实现盈利的开关已开启</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
<p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Blue Bird 并不在名单上。</p>
<p>虽然 Blue Bird 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

BLBD

<p>先锋集团（Vanguard Group Inc.）在第四季度将其在蓝鸟公司（Blue Bird Corporation，NASDAQ:BLBD）的持股增加了 7.1%，目前持有 2,041,085 股，估值约为 9593 万美元。其他对冲基金也显著增加了他们的持仓。蓝鸟公司的股票开盘价为 71.00 美元，市值为 22.5 亿美元，市盈率为 17.44。该公司报告的季度每股收益为 1.00 美元，超出预期，尽管同比收入下降了 1.7%。近期有内部人士出售股票的情况，分析师评级各异，部分分析师下调了评级并调整了目标价格</p>

<p>Vanguard Group Inc. lifted its holdings in shares of Blue Bird Corporation (NASDAQ:BLBD - Free Report) by 7.1% during the 4th quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 2,041,085 shares of the company's stock after purchasing an additional 135,562 shares during the quarter. Vanguard Group Inc. owned about 6.46% of Blue Bird worth $95,931,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>先锋集团在最近向证券交易委员会的披露中表示，在第四季度将其在蓝鸟公司（NASDAQ:BLBD - 免费报告）股票的持股比例提高了 7.1%。该基金在季度内购买了 135,562 股后，持有该公司 2,041,085 股股票。截至其最近的 SEC 备案，先锋集团持有蓝鸟约 6.46% 的股份，价值为 95,931,000 美元。</p>
</div><ul>
<li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>对于看涨投资者的三大高风险高回报投资</li>
</ul>
</div><p>Other hedge funds have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Blue Bird by 10,028.6% during the third quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $41,000 after purchasing an additional 702 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Blue Bird by 1,742.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,308 shares of the company's stock worth $75,000 after buying an additional 1,237 shares during the period. NewEdge Advisors LLC raised its position in shares of Blue Bird by 30.9% in the 1st quarter. NewEdge Advisors LLC now owns 2,885 shares of the company's stock worth $93,000 after buying an additional 681 shares during the period. LSV Asset Management purchased a new position in shares of Blue Bird in the 3rd quarter worth $98,000. Finally, Jones Financial Companies Lllp raised its position in shares of Blue Bird by 184.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,903 shares of the company's stock worth $110,000 after buying an additional 1,233 shares during the period. Institutional investors and hedge funds own 93.59% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金也对该公司的持仓进行了调整。凯通国际资产管理有限公司在第三季度将其在蓝鸟的持股比例提高了 10,028.6%。凯通国际资产管理有限公司现在拥有 709 股该公司的股票，价值 41,000 美元，此前在上个季度又购买了 702 股。拉森金融集团在第三季度将其在蓝鸟的持仓提高了 1,742.3%。拉森金融集团现在拥有 1,308 股该公司的股票，价值 75,000 美元，此前在此期间又购买了 1,237 股。NewEdge Advisors LLC 在第一季度将其在蓝鸟的持仓提高了 30.9%。NewEdge Advisors LLC 现在拥有 2,885 股该公司的股票，价值 93,000 美元，此前在此期间又购买了 681 股。LSV 资产管理公司在第三季度购买了蓝鸟的新头寸，价值 98,000 美元。最后，琼斯金融公司在第三季度将其在蓝鸟的持仓提高了 184.0%。琼斯金融公司现在拥有 1,903 股该公司的股票，价值 110,000 美元，此前在此期间又购买了 1,233 股。机构投资者和对冲基金持有该公司 93.59% 的股票。</p>
</div><h2>Blue Bird Trading Up 2.4%</h2>
<div class="lb-trans"><h2>蓝鸟股价上涨 2.4%</h2>
</div><p>NASDAQ:BLBD opened at $71.00 on Thursday. The business's 50-day moving average is $59.99 and its two-hundred day moving average is $54.94. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.83 and a quick ratio of 1.27. Blue Bird Corporation has a 12 month low of $37.68 and a 12 month high of $81.51. The firm has a market capitalization of $2.25 billion, a PE ratio of 17.44, a price-to-earnings-growth ratio of 0.97 and a beta of 1.38.</p>
<div class="lb-trans"><p>NASDAQ:BLBD 周四开盘价为 71.00 美元。该公司的 50 日移动平均线为 59.99 美元，200 日移动平均线为 54.94 美元。公司的债务与股本比率为 0.28，流动比率为 1.83，速动比率为 1.27。蓝鸟公司的 12 个月低点为 37.68 美元，12 个月高点为 81.51 美元。该公司的市值为 22.5 亿美元，市盈率为 17.44，市盈率增长比率为 0.97，贝塔值为 1.38。</p>
</div><ul>
<li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li>
</ul>
<div class="lb-trans"><ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
</div><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The company had revenue of $352.64 million for the quarter, compared to analyst estimates of $335.23 million. During the same period last year, the company posted $0.96 earnings per share. The firm's revenue was down 1.7% compared to the same quarter last year. Research analysts predict that Blue Bird Corporation will post 4.35 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最近于 5 月 6 日发布了季度财报。该公司报告季度每股收益为 1.00 美元，超出市场共识预期的 0.88 美元，超出 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司季度收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。去年同期，该公司每股收益为 0.96 美元。与去年同期相比，该公司的收入下降了 1.7%。研究分析师预测蓝鸟公司在当前财政年度将发布 4.35 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Blue Bird news, CFO Razvan Radulescu sold 3,925 shares of the firm's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $60.98, for a total value of $239,346.50. Following the transaction, the chief financial officer directly owned 42,255 shares of the company's stock, valued at $2,576,709.90. This trade represents a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Jeffrey Scott Sanfrey sold 5,192 shares of the firm's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the transaction, the chief operating officer directly owned 39,011 shares in the company, valued at $2,283,703.94. This trade represents a 11.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.10% of the company's stock.</p>
<div class="lb-trans"><p>在其他蓝鸟新闻中，首席财务官 Razvan Radulescu 于 2 月 19 日星期四出售了 3,925 股该公司的股票。股票以平均价格 60.98 美元出售，总价值为 239,346.50 美元。交易后，首席财务官直接持有 42,255 股该公司的股票，价值为 2,576,709.90 美元。这笔交易代表其持股比例减少了 8.50%。该交易在向 SEC 提交的文件中披露，文件可通过此超链接获取。此外，首席运营官 Jeffrey Scott Sanfrey 于 3 月 4 日星期三出售了 5,192 股该公司的股票。股票以平均价格 58.54 美元出售，总价值为 303,939.68 美元。交易完成后，首席运营官直接持有 39,011 股该公司的股票，价值为 2,283,703.94 美元。这笔交易代表其持股比例减少了 11.75%。该销售的 SEC 备案提供了更多信息。公司内部人士持有该公司 1.10% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Gene therapy: Why does it cost millions for a single treatment?</li>
</ul>
<div class="lb-trans"><ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
</div><p>Several brokerages recently weighed in on BLBD. Wall Street Zen lowered Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, February 7th. Freedom Capital lowered Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, May 7th. Zacks Research lowered Blue Bird from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Monday. Needham &amp; Company LLC increased their target price on Blue Bird from $78.00 to $86.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, May 7th. Finally, Barclays increased their target price on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Blue Bird presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p>
<div class="lb-trans"><p>几家券商最近对 BLBD 进行了评估。华尔街 Zen 在 2 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “买入”。Freedom Capital 在 5 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “持有”。Zacks Research 在周一的研究报告中将蓝鸟的评级从 “持有” 下调至 “强烈卖出”。Needham &amp; Company LLC 在 5 月 7 日的研究报告中将蓝鸟的目标价从 78.00 美元提高至 86.00 美元，并给予该股票 “买入” 评级。最后，巴克莱在 5 月 7 日的研究报告中将蓝鸟的目标价从 55.00 美元提高至 75.00 美元，并给予该股票 “增持” 评级。六位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，蓝鸟目前的平均评级为 “适度买入”，共识目标价为 75.80 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Blue Bird</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的蓝鸟股票分析</strong></p>
</div><h2>About Blue Bird</h2>
<div class="lb-trans"><h2>关于蓝鸟</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Blue Bird Corporation NASDAQ: BLBD is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.</p>
<div class="lb-trans"><p>蓝鸟公司（NASDAQ: BLBD）是总部位于乔治亚州福特谷的领先公交车和公共交通工具制造商。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）模型、公交风格（D 型）模型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩展了其产品，推出了零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
</div><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p>
<div class="lb-trans"><p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Blue Bird</li>
<li>D-Wave Earnings Looked Weak, But Investors May Be Missing This</li>
<li>Nebius Upside Expands as AI Feedback Loop Intensifies</li>
<li>Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell</li>
<li>Plug Power Flips The Switch On Profitability</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Blue Bird</li>
<li>D-Wave 的财报表现疲软，但投资者可能忽视了这一点</li>
<li>随着 AI 反馈循环加剧，Nebius 的上行空间扩大</li>
<li>内部交易：Okta 和 Abbott 看到买入，Micron 内部人士卖出</li>
<li>Plug Power 实现盈利的开关已开启</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=BLBD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
</div><p>Before you consider Blue Bird, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Blue Bird 并不在名单上。</p>
</div><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Blue Bird 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Blue Bird Corporation $BLBD Shares Acquired by Vanguard Group Inc.

Market Beat

Vanguard Group Inc. 收购了 Blue Bird Corporation $BLBD 的股份